Stocks
Alnylam Pharmaceuticals (ALNY) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -403.2% | -174.1% | -101.0% | -109.0% | -24.1% | -15.9% | ||
| Changes by years, y/y, % | +613pp | +229pp | +73pp | -8pp | +85pp | -52.7% | |||
Alnylam Pharmaceuticals. Net margin, %
Alnylam Pharmaceuticals. Net margin, changes, pp
Alnylam Pharmaceuticals (ALNY) Net margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net margin, % | ? | 19.7% | -31.4% | -13.3% | -2.56% | -22.3% | -15.9% | |
| Changes by years, y/y, % | +173pp | +31pp | +41pp | +84pp | -42pp | |||
| Changes by quarters, q/q, % | +106pp | -51pp | +18pp | +11pp | -20pp | |||
